Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At The Third Annual Marcum Microcap Conference In NYC On May 29th
5/19/2014 6:49:46 AM
Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Dr. Kaushik J. Dave, President and CEO of Actinium will be a featured presenter at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel.
Help employers find you! Check out all the jobs and post your resume.
comments powered by